The UK Dementia Research Institute has received major new government funding to boost translational research into dementia and related neurodegenerative conditions such as Parkinson’s and motor neuron disease.

The UK-wide research institute will receive an initial £20 ($25.9) million from the National Institute for Health and Care Research (NIHR).

The funding will enable new national and international research collaborations, to generate new scientific insights from diverse cohort datasets.

This will include training the next generation of delivery scientists and health practitioners in dementia, and new artificial intelligence (AI) and data initiatives to accelerate the discovery of new therapies.

With the UK’s ageing population and number of dementia cases projected to rise to 1.4 million by the year 2040, the institute says there is an urgent need to capitalise on scientific progress to safeguard the nation’s health and protect public services.

UK Dementia Research Institute’s Director, Professor Siddharthan Chandran, said: “This far-sighted investment will be catalytic in helping accelerate the translation of scientific discoveries into therapeutic impact. After many false dawns, the field is on the cusp of major breakthroughs and we will move from late and imprecise diagnosis with no effective disease-slowing therapies to precision diagnosis and the first wave of therapies.”

Working with global partners, UK Dementia Research Institute scientists will collaborate to gain broader insights from data from human studies across the globe.

Chief Scientific Adviser, Department of Health and Social Care (DHSC) and Chief Executive Officer of the National Institute for Health and Care Research (NIHR), Professor Lucy Chappell said: “With the UK’s aging population, dementia continues to be a crucial area of research in our country and it is essential we develop strategies to diagnose early and treat this disease effectively.”

Diana Spencer, Senior Digital Content Editor, DDW